General form of registration statement for all companies including face-amount certificate companies

BASIS OF PRESENTATION AND CHANGE IN ACCOUNTING POLICY

v3.10.0.1
BASIS OF PRESENTATION AND CHANGE IN ACCOUNTING POLICY
12 Months Ended
Mar. 31, 2018
Disclosure Text Block [Abstract]  
Basis Of Presentation And Change In Accounting Policies [Text Block]
2.
BASIS OF PRESENTATION AND CHANGE IN ACCOUNTING POLICY
 
a)
Basis of presentation
 
On or about August 7, 2018, holders of the common stock and exchangeable shares of the Company approved, through a majority shareholder vote, an amendment to the Company’s Amended and Restated Certificate of Incorporation authorizing the Board of Directors to effect a reverse stock split of Bionik’s common stock and exchangeable shares at a ratio up to one-to-one hundred and fifty.
 
On October 29, 2018, the Company effected a reverse stock split and thereafter Bionik’s common stock began trading on the OTCQB market on a one-for-one hundred and fifty (1:150) split-adjusted basis. All owners of record on October 29, 2018 received one issued and outstanding share of Bionik common stock or exchangeable share in exchange for one hundred and fifty issued and outstanding shares of Bionik common stock or Bionik exchangeable stock. No fractional shares were issued in connection with the reverse stock split. All fractional shares created by the one-for-one hundred and fifty exchange were rounded up to the next whole share. The reverse stock split had no impact on the par value per share of Bionik common stock, which remains at $0.001. All current and prior period amounts related to shares, share prices and earnings per share, presented in the Company’s consolidated financial statements and the accompanying Notes have been restated to give retrospective presentation for the reverse stock split.
 
b)
Change in accounting policy
 
The FASB issued ASU No. 2017-11, 
Earnings Per Share (Topic 260) Distinguishing Liabilities From Equity (Topic 480) Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments With Down Round Feature II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests With a Scope Exception
, allows a financial instrument with a down-round feature to no longer automatically be classified as a liability solely based on the existence of the down-round provision. The update also means the instrument would not have to be accounted for as a derivative and be subject to an updated fair value measurement each reporting period.
 
On consideration of the above factors, the Company elected to early adopt ASU 2017-11 on July 1, 2017, the ASU is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018. For all other organizations, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020.
 
The early adoption allows the Company to reduce the cost and complexity of updating the fair value measurement each reporting period and eliminate the unnecessary volatility in reported earnings created by the revaluation when the Company’s shares’ value changes.
 
The Company presented the change in accounting policy through the retrospective application of the new accounting principle to all prior periods, as described in ASU No. 250-10-45-5, Accounting Changes and Error Corrections.
The following financial statement line items for the year ended
March 31, 2017
were affected by the change in accounting principle.
 
Income Statement
 
         
As of
       
   
As originally
   
March 31, 2017
   
Effect
 
   
reported
   
As adjusted
   
of change
 
Sales   $ 571,945     $ 571,945     $ -  
Cost of Sales     388,756       388,756       -  
Total operating expenses     8,829,481       8,829,481       -  
Total other expenses     (4,709,718 )     (576,890 )     (4,132,828 )
Net income (loss) and comprehensive loss for the Period     (3,936,574 )     (8,069,402 )     (4,132,828 )
Basic loss per share     (6.00 )     (13.19 )     (7.50 )
Diluted loss per share     (6.00 )     (13.19 )     (7.50 )
 
Balance sheet
 
As a result of the accounting policy change, the Company’s deficit as of April 1, 2017 increased from ($15,588,554), as originally reported under ASU No. 2016-01, to ($21,076,464) using ASU No. 2017-11.
 
   
 
As originally
reported
   
As at

March 31, 2017
As adjusted
   
 
Effect
of change
 
Balance Sheet
                 
Current assets   $ 1,402,580     $ 1,402,580     $ -  
Capital assets     227,421       227,421       -  
Intangible assets     27,338,899       27,338,899       -  
Total assets   $ 28,968,900     $ 28,968,900     $ -  
Warrant derivative liability     959,600       -       (959,600 )
Other current liabilities     4,818,205       4,818,250       45  
Total liabilities   $ 5,777,805     $ 4,818,250     $ (959,555 )
Common stock     645       645       -  
Additional paid in capital     38,736,855       45,184,320       6,447,465  
Deficit     (15,588,554 )     (21,076,464 )     (5,487,910 )
Accumulated other comprehensive income     42,149       42,149       -  
Total shareholders’ equity   $ 23,191,095     $ 24,150,650     $ 959,555  
Total liabilities and shareholders’ equity   $ 28,968,900     $ 28,968,900     $ -  
 
Statement of cash flows
 
   
As originally
reported
   
As at 
March 31, 2017
As adjusted
   
 
Effect
of change
 
Net income (loss) for year   $ (3,936,574 )   $ (8,069,402 )   $ (4,132,828 )
Adjustment for items not affecting cash and changes in non-cash working capital items     (3,055,739 )     1,077,089       4,132,828  
Net cash (used in) operating activities     (6,992,313 )     (6,992,313 )     -  
Net cash (used in) investing activities     (170,790 )     (170,790 )     -  
Net cash provided by financing activities     2,324,996       2,324,996       -  
Net (decrease) in cash and cash equivalents for the year     (4,838,107 )     (4,838,107 )     -  
Cash and cash equivalents, beginning of year     5,381,757       5,381,757       -  
Cash and cash equivalents, end of year   $ 543,650     $ 543,650     $ -